Biomarkers could revolutionise the early detection of and therapy for Alzheimer’s disease. However, experts attending the Congress of the European Academy of Neurology (EAN) in Copenhagen criticized that the big breakthroughs are slow in coming because of a lack of priorities in research. A roadmap should help to push along advances in this area.
from Dementia Big http://ift.tt/1Wwx0Ps via alcoholic dementia
http://ift.tt/1XPlsGi
No comments:
Post a Comment